Active	Status	Sponsor type	Region	Phase	Filter
2 Active 6 Inactive 8 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Arnold, Marcel
NCT02864953 / 2017-004854-41: Phase 3 Study to Evaluate the Efficacy and Safety of Intravenous BIIB093 (Glibenclamide) for Severe Cerebral Edema Following Large Hemispheric Infarction	Terminated	3	535	Europe, Canada, Japan, US, RoW	BIIB093, glibenclamide, glibenclamide intravenous (IV), glyburide, CIRARA, Placebo	Remedy Pharmaceuticals, Inc.	Brain Edema, Stroke, Acute	08/23	08/23
I-IDIS, NCT02756091: International Intracranial Dissection Study	Recruiting	N/A	500	Europe, Japan	No study-specific intervention	Insel Gruppe AG, University Hospital Bern, Swiss Heart Foundation, Cervical Artery Dissections and Ischemic Stroke Patients - Consortium	Cerebrovascular Disorders, Vascular: Intracranial, Intimal Dissection, Stroke	11/26	11/27